Sally C. Pipes
Commentary
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Commentary
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Commentary
Industry Voices—Surprise! There’s a better fix for surprise bills
Federal health officials are trying to reignite the debate over surprise medical bills. In a report issued earlier this summer, the Department of Health and Human Services urged Congress to do something about surprise bills, saying the practice represents a market failure that cannot be corrected on its own. The ...
Commentary
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Commentary
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
Commentary
How Trump can trounce Biden on healthcare
In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Coronavirus
The Morning Rush Interviews Sally C. Pipes on COVID-19 Reopenings
Sally C. Pipes, PRI’s President and CEO, talks about how shutdowns and shelter in place orders from COVID-19 and the coronavirus are impacting elective procedures and screenings for cancer. Pipes points out that the tremendous delays in elective health care could result in an increase in cancer deaths. Pipes also ...
Commentary
Fans of Medicare for All Have an Ally in Biden
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Commentary
Trump’s Drug Pricing Order Is A Costly Mistake
On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Coronavirus
Sally C. Pipes Talks Healthcare Insurance on the Rod Arquette Show
Sally Pipes, President and CEO of the Pacific Research Institute joins Rod to discuss the struggles some people are having with health insurance during the coronavirus pandemic.
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Industry Voices—Surprise! There’s a better fix for surprise bills
Federal health officials are trying to reignite the debate over surprise medical bills. In a report issued earlier this summer, the Department of Health and Human Services urged Congress to do something about surprise bills, saying the practice represents a market failure that cannot be corrected on its own. The ...
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
How Trump can trounce Biden on healthcare
In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
The Morning Rush Interviews Sally C. Pipes on COVID-19 Reopenings
Sally C. Pipes, PRI’s President and CEO, talks about how shutdowns and shelter in place orders from COVID-19 and the coronavirus are impacting elective procedures and screenings for cancer. Pipes points out that the tremendous delays in elective health care could result in an increase in cancer deaths. Pipes also ...
Fans of Medicare for All Have an Ally in Biden
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Trump’s Drug Pricing Order Is A Costly Mistake
On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Sally C. Pipes Talks Healthcare Insurance on the Rod Arquette Show
Sally Pipes, President and CEO of the Pacific Research Institute joins Rod to discuss the struggles some people are having with health insurance during the coronavirus pandemic.
